Home Nav
Nextech Invest Logo

David M. Livingston

Alfred Scheidegger

David Livingston MD is chairman of the Nextech Invest Scientific Board and deputy director and professor of medicine and genetics, Dana-Farber Cancer Institute/Harvard Cancer Center, Harvard Medical School, USA, and a physician at Brigham and Women's Hospital, USA. He is the former chairman of the board of scientific advisors of the U.S. National Cancer Institute, a member of the Institute of Medicine of the National Academy of Sciences and its Institute of Medicine, USA, among other such bodies, and a consultant to numerous oncology companies.

 

19TH ANNUAL BIO€QUITY EUROPE

14.05. – 16.05.2018

Ghent, Belgium

  • 25.04.2018

    Blueprint Medicines to report first quarter 2018 financial...

  • 23.04.2018

    Autolus announces license agreement with UCL Business...

  • 17.04.2018

    Autolus announces presentation of preliminary data showing...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close